Does tumor necrosis factor play a role in the pathogenesis of fulminant hepatitis?
- 30 November 1988
- journal article
- Published by Elsevier in Medical Hypotheses
- Vol. 27 (3) , 193-196
- https://doi.org/10.1016/0306-9877(88)90140-5
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Tumour necrosis factors α and β inhibit virus replication and synergize with interferonsNature, 1986
- Control of Cachectin (Tumor Necrosis Factor) Synthesis: Mechanisms of Endotoxin ResistanceScience, 1986
- Modulation of endothelial cell hemostatic properties by tumor necrosis factor.The Journal of Experimental Medicine, 1986
- Fibroblast growth enhancing activity of tumor necrosis factor and its relationship to other polypeptide growth factors.The Journal of Experimental Medicine, 1986
- Recombinant Human Tumor Necrosis Factor-α: Effects on Proliferation of Normal and Transformed Cells in VitroScience, 1985
- Increase of vulnerability to lymphotoxin in cells infected by vesicular stomatitis virus and its further augmentation by interferonCellular Immunology, 1985
- Lack Of In Vivo Activation of the Interferon System in Hbsag–Positive Chronic Active HepatitisHepatology, 1985
- Human tumour necrosis factor: precursor structure, expression and homology to lymphotoxinNature, 1984
- Serological markers in fulminant hepatitis B.Gut, 1983
- CELLULAR IMMUNITY AND HEPATITIS-ASSOCIATED, AUSTRALIA ANTIGEN LIVER DISEASEThe Lancet, 1972